Skip to the main content.
Contact Us
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer

Picture of Web Admin Web Admin Jun 24, 2022 4:29:23 PM

Liquid Biopsy Article Oncology Metastasis IsoFlux

ACCESS TO ARTICLE→